Arrowstreet Capital’s MediciNova MNOV Stock Holding History

Arrowstreet Capital’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,458	Closed	-$71K	–	2445
2020 Q3	$71K	Buy	+13,458	New	+$77.6K	﹤0.01%	2274

Other funds holding MNOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JSMC

Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital's MNOV Position: Q4 2020 in Review

Arrowstreet Capital sold out of MediciNova (MNOV) in Q4 2020, closing a stake of 13,458 shares — an estimated $71K sold.

Arrowstreet Capital first reported a position in MNOV in Q3 2020 and held it in 1 quarter. The position peaked at $71K in Q3 2020. 57 funds tracked by Wall St. Rank hold MNOV as of Q4 2020.

Arrowstreet Capital reported no remaining MediciNova position as of Q4 2020 after selling out during the quarter.
Arrowstreet Capital sold 13,458 MediciNova shares in Q4 2020, an estimated $71K.
Arrowstreet Capital first reported a position in MediciNova in Q3 2020 and held it in 1 quarter.
Arrowstreet Capital's MediciNova position peaked at $71K in Q3 2020.
57 funds tracked by Wall St. Rank held MediciNova as of Q4 2020.

Based on Arrowstreet Capital's 13F filing for Q4 2020, filed 12 Feb 2021.